Angiotensin receptor blockers for the treatment of covid-19 Post date 17 November 2022 ← Flow model for emergency departments: putting the cart before the horse → Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community